Export 00
Novoeight Kit
Product Images NDC 0169-7850
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Novoeight (NDC 0169-7850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Export 01
Export 02
Export 03
Export 04
Export 05
Overview (Image 01)
Figure A (Image 02)
Figure B (Image 03)
Figure C (Image 04)
Figure D (Image 05)
Figure E (Image 06)
Fig. F (Image 07)
Figure G (Image 08)
Figure H (Image 09)
Figure I (Image 10)
Figure J (Image 11)
Figure K (Image 12)
Overview (Image 13)
Figure A (Image 14)
Figure B (Image 15)
Fig. C (Image 16)
Figure D (Image 17)
Fig. E (Image 18)
Fig. F (Image 19)
Fig. G (Image 20)
Fig. H (Image 21)
Fig. I (Image 22)
Fig J (Image 23)
I (Image 24)
Figure K (Image 25)
Fig. L (Image 26)
Fig. M (Image 27)
250 Iu Vial Label (Image 34)
This appears to be a label for a medication called "Novoeight", which is an antihemophilic used to treat hemophilia. It is a recombinant medication that should be stored in a refrigerator between 36 and 46 degrees Fahrenheit.*
500 Iu Vial (Image 35)
This appears to be a label or packaging information for a medication called "Novoeight" with the National Drug Code (NDC) 0169-7851-11. The medication may be related to "Anthemophikc" and "Facwr Reconetution," possibly indicating its use for blood clotting disorders. It also mentions "Recombinant" and "4 mL sodium," potentially referring to the manufacturing process and ingredients of the medication. There is a temperature range of refrigerator storage provided as well.*
1000 Iu Vial (Image 36)
NDC 0169 7811 11 refers to the medication Novoeight, which is a recombinant factor that helps with anti-hemophilic treatment. The dosage and other details about the package are not available as they have been excluded or lost during .*
1500 Iu Vial (Image 37)
Novoeight is a medicine used to treat bleeding episodes in patients with hemophilia A. It is an antihemophilic factor, specifically a recombinant factor VIII. Its National Drug Code (NDC) is 0169-7855-11.*
2000 Iu Vial (Image 38)
This appears to be a product label for Novoeight, a recombinant medication with a concentration of 2000 U. No other information is available due to the limited and fragmented nature of the text.*
3000 Iu Vial (Image 39)
This appears to be a product label for a medication called "Novoeight." It is an antihemophilic factor, which is a type of protein used for treating bleeding episodes in people with hemophilia A. The medication is stored in a refrigerator and should not be frozen. It comes in a powder form and must be reconstituted with a certain amount of sodium chloride solution. The label also includes a lot number and a National Drug Code (NDC) number.*
Syringe Label (Image 40)
This is a description of the NDC 0169 7008 98 solution, which is Sodium Chloride Solution that is used for reconstitution of Novoeight. It is advised to store it in a refrigerator between 36°F to 46°F and not to freeze it. The package is for single use only and there is an expiry date mentioned on it. The lot number is also disclosed which is 1-844.30-EIGHT and it is manufactured by the company Novo Nordisk inc.*
Symbol (Image 41)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
